Mesenchymal stem cells for mitigating radiotherapy side effects

38Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Radiation therapy for cancers also damages healthy cells and causes side effects. Depending on the dosage and exposure region, radiotherapy may induce severe and irreversible injuries to various tissues or organs, especially the skin, intestine, brain, lung, liver, and heart. Therefore, promising treatment strategies to mitigate radiation injury is in pressing need. Recently, stem cell‐based therapy generates great attention in clinical care. Among these, mesenchymal stem cells are extensively applied because it is easy to access and capable of mesodermal differentiation, immunomodulation, and paracrine secretion. Here, we summarize the current attempts and discuss the future perspectives about mesenchymal stem cells (MSCs) for mitigating radiotherapy side effects.

Cite

CITATION STYLE

APA

Wang, K. X., Cui, W. W., Yang, X., Tao, A. B., Lan, T., Li, T. S., & Luo, L. (2021, February 1). Mesenchymal stem cells for mitigating radiotherapy side effects. Cells. MDPI. https://doi.org/10.3390/cells10020294

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free